1.57
                                            Schlusskurs vom Vortag:
              $1.54
            Offen:
              $1.57
            24-Stunden-Volumen:
                166.04K
            Relative Volume:
              0.18
            Marktkapitalisierung:
                $84.08M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-151.16M
            KGV:
              -0.5286
            EPS:
                -2.97
            Netto-Cashflow:
                $-130.08M
            1W Leistung:
              -7.65%
            1M Leistung:
              -27.98%
            6M Leistung:
                +194.61%
            1J Leistung:
              +8.28%
            Alx Oncology Holdings Inc Stock (ALXO) Company Profile
Firmenname
                  
                      Alx Oncology Holdings Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      650-466-7125
                    
                Adresse
                  
                      323 ALLERTON AVENUE, SOUTH SAN FRANCISCO
                    
                Vergleichen Sie ALXO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                ALXO
                            
                             
                        Alx Oncology Holdings Inc 
                           | 
                    1.57 | 82.47M | 0 | -151.16M | -130.08M | -2.97 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Alx Oncology Holdings Inc Stock (ALXO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-03-06 | Hochstufung | Jefferies | Hold → Buy | 
| 2024-12-19 | Herabstufung | Jefferies | Buy → Hold | 
| 2024-03-08 | Herabstufung | Stifel | Buy → Hold | 
| 2023-12-08 | Hochstufung | Jefferies | Hold → Buy | 
| 2021-12-22 | Herabstufung | Jefferies | Buy → Hold | 
| 2021-09-30 | Eingeleitet | Stifel | Buy | 
| 2021-05-05 | Fortgesetzt | Credit Suisse | Outperform | 
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform | 
| 2021-04-06 | Eingeleitet | UBS | Buy | 
| 2021-02-10 | Eingeleitet | H.C. Wainwright | Buy | 
| 2020-08-11 | Eingeleitet | Cantor Fitzgerald | Overweight | 
| 2020-08-11 | Eingeleitet | Credit Suisse | Outperform | 
| 2020-08-11 | Eingeleitet | Jefferies | Buy | 
| 2020-08-11 | Eingeleitet | Piper Sandler | Overweight | 
                    Alle ansehen
                    
                  
                Alx Oncology Holdings Inc Aktie (ALXO) Neueste Nachrichten
Will ALX Oncology Holdings Inc. stock reach Wall Street targetsDollar Strength & High Yield Equity Trading Tips - newser.com
Can ALX Oncology Holdings Inc. stock attract ESG capital inflowsTrade Volume Report & Daily Entry Point Alerts - newser.com
Is ALX Oncology Holdings Inc. stock attractive for hedge fundsSell Signal & Technical Pattern Recognition Alerts - newser.com
Statistical indicators supporting ALX Oncology Holdings Inc.’s strengthRisk Management & Free High Accuracy Swing Entry Alerts - newser.com
Will ALX Oncology Holdings Inc. continue its uptrendJuly 2025 EndofMonth & High Accuracy Swing Entry Alerts - newser.com
Can ALX Oncology Holdings Inc. hit a new high this monthJuly 2025 Intraday Action & AI Forecasted Entry/Exit Points - newser.com
Analyzing ALX Oncology Holdings Inc. with risk reward ratio charts2025 Bull vs Bear & Precise Swing Trade Entry Alerts - newser.com
Is ALX Oncology Holdings Inc. stock a buy before product launches2025 Market Sentiment & Free Community Consensus Stock Picks - newser.com
Analyzing recovery setups for ALX Oncology Holdings Inc. investorsJuly 2025 Setups & Safe Capital Growth Stock Tips - newser.com
How to build a dashboard for ALX Oncology Holdings Inc. stockJuly 2025 Highlights & Capital Protection Trade Alerts - newser.com
Key metrics from ALX Oncology Holdings Inc.’s quarterly dataTrade Risk Assessment & Low Risk High Reward Ideas - newser.com
ALX Oncology Holdings Inc. (ALXO) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Will ALX Oncology Holdings Inc. outperform the marketWeekly Volume Report & Weekly Breakout Opportunity Watchlist - newser.com
Will ALX Oncology Holdings Inc. benefit from macro trendsChart Signals & High Win Rate Trade Alerts - newser.com
Visual analytics tools that track ALX Oncology Holdings Inc. performanceRecession Risk & AI Optimized Trade Strategies - newser.com
Building trade automation scripts for ALX Oncology Holdings Inc.Trade Entry Report & Consistent Profit Alerts - newser.com
ALX Oncology (ALXO) Expected to Announce Earnings on Thursday - MarketBeat
ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting - The Manila Times
ALX Oncology (NASDAQ: ALXO) to review biomarker data at SITC, report Q3 2025 results - Stock Titan
ALX Oncology’s ASPEN-09 Study: A Promising Update for Cancer Treatment - MSN
Finanzdaten der Alx Oncology Holdings Inc-Aktie (ALXO)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):